Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Rapid, comprehensive and sensitive method for neoantigen screening from recurrent cancer mutations

Rapid, comprehensive and sensitive method for neoantigen screening from recurrent cancer mutations

US Patent 12277997 · Granted Apr 15, 2025

Assignee

No assignee recorded.

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Method for identifying a shared neoantigen-reactive T cell receptor2025